Navigation Links
Understanding The Risks Of Hormone Therapy

Women who take hormone therapy that combines estrogen with progestin have double the risk for venous thrombosis ( VT ), a type of blood clot,// according to a recent study.

VT affects one to two people in every 1,000. Risk for VT increases with age and is higher in men, blacks and obese individuals. Postmenopausal hormone therapy is associated with a two- to three-fold increased risk of VT.

Researchers studied 16,608 postmenopausal women between ages 50 and 79 years. Participants were randomly assigned to an estrogen drug combination or a placebo. VT occurred in 167 women taking estrogen plus progestin but in only 76 taking placebo. The risk for VT was more than four-times greater in women in their 60s than 50s and more than seven-times greater for women in their 70s. Obese women had a nearly six-times greater risk for VT than normal-weight women.

Researchers say, based on their projections for 10 years for 1,000 women taking estrogen plus progestin, the estimated excess number of events is 18 for VT, six for coronary heart disease, eight for invasive breast cancer, and eight for stroke. Thus researchers say their findings may be important for the use of postmenopausal hormone therapy in the treatment of menopausal symptoms among younger postmenopausal women.

Page: 1

Related medicine news :

1. Understanding The Predictors Of Prostate Cancer
2. Understanding Restless Legs Syndrome
3. Understanding Lung Cancer Metastasis
4. Understanding The Link Between Hormone Replacement and Respiratory Disease
5. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
6. A Better Understanding Of The Brain Network
7. Understanding The Predictor’s Of Alzheimer’s Diseae
8. Understanding The Harmful Effects Of Radiation Exposure
9. Understanding The Origin Of Tumors
10. Understanding Insulin Resistance
11. Understanding The Link Between Phobias And Fatal Heart Disease
Post Your Comments:

(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology: